Patient Leaflet Updated 25-Mar-2025 | Baxter Healthcare Ltd
Propofol 10 mg/ml Emulsion for injection/infusion
Propofol 10 mg/ml Emulsion for injection/infusion
propofol
1. What Propofol 10 mg/ml is and what it is used for
2. What you need to know before you are given Propofol 10 mg/ml
3. How you are given Propofol 10 mg/ml
4. Possible side effects
5. How to store Propofol 10 mg/ml
6. Contents of the pack and other information.
Propofol 10 mg/ml contains an active substance called propofol. Propofol 10 mg/ml belongs to a group of medications that are called general anaesthetics. General anaesthetics are used to trigger unconsciousness (a type of sleep), so that surgeries and other treatments can be performed. They can also be used for sedation (so that you are sleepy but are not really sleeping).
Propofol 10 mg/ml is used for:
Talk to your doctor, anaesthetist or nurse before using Propofol10 mg/ml:
You may feel affected after using Propofol. You should therefore be accompanied by someone when you leave the hospital.
The use of Propofol 10 mg/ml in newborns is not recommended, since this patient group has not been sufficiently evaluated.
Propofol may not be used for sedation in patients 16 years of age or younger during intensive care, since the safety and efficacy of Propofol has not been validated for sedation in this age group.
In the case of elderly patients, smaller doses are required for the induction of anaesthesia with Propofol 10 mg/ml. The patient’s general state of health and age should be taken into account.
The lowered dose should be administered more slowly and titrated according to the reaction.
Tell your doctor if you are taking/using, have recently taken/used or might take/use any other medicines.
In particular, tell your doctor, anaesthetist or nurse if you are taking any of the following medicines:
You may not ingest any alcohol after the administration of Propofol 10 mg/ml .
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine
Pregnancy
Propofol 10 mg/ml should only be used during pregnancy if absolutely necessary.
Breast-feeding
Studies with breast-feeding women have shown that Propofol passes into breast milk in small quantities.
Therefore, mothers should suspend breast-feeding for up to 24 hours after administration of Propofol and discard the corresponding breast milk.
After having propofol, you may still feel sleepy for some time.
Do not drive or use any tools or machines until you are sure the effects have worn off.
Propofol contains soya-bean oil. If you are allergic to peanut or soya, do not use this medicinal product.
This medicinal product contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially ‘sodium-free’.
Propofol 10 mg/ml will be given to you as an injection or infusion into a vein. This is usually in the back of your hand or in your forearm.
Propofol 10 mg/ml may only be administered by doctors that have been trained in anaesthesiology or intensive care. Sedation or anaesthesia with Propofol 10 mg/ml and the surgical or diagnostic procedure may not be performed by the same person.
You may need several different medicines to keep you asleep or sleepy, free from pain, breathing in a healthy way and to keep your blood pressure steady. The doctor will decide which medicines you need and when you need them.
The administered dose varies depending on the age, body weight, the general physical state of health and the premedication. The doctor will use appropriate dose for induction and maintenance of anaesthesia or for achieveing the required depth of sedation, while carefully observing the physical responses and vital signs (pulse, blood pressure, breathing, etc).
If you have any further questions on the use of this medicine, ask your doctor.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The induction and maintenance of anaesthesia and sedation with Propofol is normally gentle with only a few signs of excitation. The most frequently reported side effects are a decrease in blood pressure and impairment of the response from the breathing centre (respiratory depression). The type, severity and frequency of these effects, which were observed in patients that were receiving Propofol, are dependent on the patient’s state of health, the type of procedure and the therapeutic measures taken.
The following side effects were particularly observed:
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Very rare (may affect up to 1 in 10,000 people)
Not known: The frequency cannot be estimated on the basis of the available data
After simultaneous administration of lidocaine, the following side effects can occur rarely:
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and the vial label after EXP. The expiry date refers to the last day of that month.
Store below 25° C.
Do not freeze.
After opening the product must be used immediately.
Dilutions with glucose 50 mg/ml (5%) solution for injection, sodium chloride 9 mg/ml (0.9%) solution for injection or sodium chloride 1.8 mg/ml (0.18%) and glucose 40 mg/ml (4%) solution for injection and preservative-free lidocaine 10 mg/ml (1%) solution for injection. The mixture should be prepared aseptically (controlled and validated conditions preserved) immediately prior to administration and must be administered within 12 hours after preparation.
Containers should be shaken before use.
If two layers can be seen after shaking the emulsion should not be used.
Use only homogeneous preparations and undamaged containers.
For single use. Any unused emulsion must be discarded.
Your anaesthetist and hospital pharmacist are responsible for the correct storage, use and disposal of Propofol.
The active substance is propofol.
Each ml of emulsion for injection/infusion contains 10 mg of propofol.
Each 20 ml vial contains 200mg of propofol
Each 50 ml vial contains 500mg of propofol
Each 100 ml vial contains1000mg of propofol.
The other ingredients are: Soya-bean oil refined, Medium-chain triglycerides, Glycerol, Egg lecithin, Sodium oleate, Sodium Hydroxide (for pH adjustment) and Water for injections.
White oil-in-water emulsion for injection/infusion.
This medicinal product is supplied as:
Emulsion for injection/infusion in colourless glass vial (type II glass) with grey bromo butyl rubber stopper.
Pack sizes:
Colourless glass vial (type II) of 20 ml with grey bromobutyl rubber closure, packs of 1, 5 and 10 unit
Colourless glass vial (type II) of 50 ml with grey bromobutyl rubber closure, packs of 1 and 10 unit
Colourless glass vial (type II) of 100 ml with grey bromobutyl rubber closure, packs of 1 and 10 unit
Not all pack sizes may be marketed.
United Kingdom
Ireland:
This medicinal product is authorized in the Member States of EEA under the following names:
CMS country Invented Names
Germany (RMS) Propofol Baxter 10 mg/ml MCT Emulsion zur Injektion/Infusion
Austria Propofol Baxter 1% (10 mg/ml) MCT Emulsion zur Injektion/Infusion
Czech Republic Anesia 10 mg/ml injekční/infuzní emulze Denmark Profast 10mg/ml, injektions- og infusionsvæske, emulsion
Estonia Anesia
Greece Propofol/Baxter 10 mg/ml Γαλάκτωμα για ένεση/έγχυση
Finland Profast 10 mg/ml injektio-/infuusioneste, emulsio
France PROPOFOL BAXTER 10 mg/ml, emulsion injectable/pour perfusion
Hungary Anesia 10 mg/ml emulziós injekció vagy infúzió
Ireland Propofol 10mg/ml Emulsion for Injection/ Infusion
Italy Rapiva 10 mg/ml emulsione iniettabile e per infusion
Latvia Anesia 10 mg/ml emulsija injekcijām/ infūzijām
Lithuania Anesia 10 mg/ml injekcinė/infuzinė emulsija
Netherlands Propofol Spiva 10 mg/ml, emulsie voor injectie of infusie
Norway Profast 10 mg/ml injeksjons-/infusjonsvæske, emulsjon
Poland Propofol Baxter, 10mg/ml, emulsja do wstrzzykiwań/ do infuzji
Portugal Propofol Baxter 10 mg/ml emulsão injectável ou para perfusão
Romania Profast 10mg/ml emulsie injectabila/ perfuzabila
Sweden Profast 10 mg/ml injektionsvätska/ infusionsvätska, emulsion
Slovenia Anesia 10 mg/ml emulzija za injiciranje ali infundiranje
UK Propofol 10 mg/ml Emulsion for injection/ infusion
This Leaflet was last revised in 07/2024.
1400008628
Caxton Way, Thetford, Norfolk, IP24 3SE, UK
0800 0260516
https://medinfo.baxterhealthcare.co.uk
https://www.baxterhealthcare.co.uk/
0800 028 9881